GlassScriptPhysician profile
Lilly Zhu
NPI 1023404597
$5,415.10
in general payments reported to CMS, 2019-2025
38 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.00 · 2020: $416 · 2021: $284 · 2022: $622 · 2023: $1,012 · 2024: $1,417 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,802 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,802.23 |
| Education | $207.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,100.41 | 2020-2025 | Skyrizi, Botox |
| Janssen Biotech, INC. | $947.11 | 2020-2025 | Tremfya |
| Pfizer INC. | $350.57 | 2019-2025 | |
| Amgen INC. | $320.86 | 2019-2025 | Otezla, Otezla |
| Lilly USA, LLC | $306.41 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $283.29 | 2019-2025 | |
| Ucb, INC. | $267.28 | 2023-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $252.33 | 2021-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $205.69 | 2021-2025 | Ilumya |
| Incyte Corporation | $171.64 | 2021-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $133.16 | 2024-2025 | |
| Galderma Laboratories, L.P. | $107.36 | 2020-2025 | Aklief, Oracea, Epsolay |
| E.R. Squibb & Sons, L.L.C. | $99.67 | 2022-2025 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $79.99 | 2023 | |
| Mayne Pharma Commercial LLC | $71.34 | 2021-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lilly Zhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.